Dow Down 0.12% Nasdaq Up 0.25%

Avanir Pharmaceuticals, Inc. (AVNR)

-NasdaqGS
5.79 Up 0.13(2.30%) 3:29PM EDT - Nasdaq Real Time Price
Prev Close:5.66
Open:5.65
Bid:5.79 x 6800
Ask:5.80 x 900
1y Target Est:9.58
Beta:1.07
Next Earnings Date:N/A
Day's Range:5.62 - 5.83
52wk Range:2.62 - 6.00
Volume:746,832
Avg Vol (3m):2,042,290
Market Cap:994.91M
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AVNR

Comparison

Symbol% ChgMkt Cap
AVNRUp 2.30%994.91M
BMYUp 0.43%83.24B
LLYUp 0.56%66.85B
GSKDown 0.01%114.56B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):9.35
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-0.29
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-0.36

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback